Control of patient information in the COVID-19 era

Blog Innovative regulation: keeping pace with genomics and software devices

16 December 2021

MHRA proposals on software and genetic testing devices are some of the most innovative and exciting developments set out for consultation.

Research Assessing AI for early detection of oesophageal cancer

A collaboration between the Universities of Cambridge, Oxford, Kings College London, the PHG Foundation and Cyted.

Blog Host genomics and COVID-19: where are we now?

25 October 2021

COVID-19 can have severe effects on even apparently low-risk individuals, and it has become clear that host factors affecting the risk of infection and disease progression include genomics.

Policy briefing Phage therapy to treat AMR infections

Phage therapy is the use of active phages to kill bacteria that cause human diseases, while leaving other bacteria unaffected.

Blog Is the latest COVID-19 virus variant a cause for concern?

26 November 2021

Genomic sequencing and analysis of SARS-CoV-2 has been crucial for both scientific understanding and public health control measures.

Report Control of patient information in the COVID-19 era

The control of patient information (COPI) notices have had significant positive impacts on COVID-19 - related research, but the success of future reforms to the use of CPI relies on building trustworthiness.

Report Polygenic scores and clinical utility

Our report unpicks the complexities of assessing the clinical utility of polygenic scores